Vimta Labs Q4 FY25 profit rises 31% YoY; announces 1:1 bonus issue and new biologics R&D foray
By News Desk Published on April 28, 2025, 19:19 IST
Vimta Labs Limited reported robust financial results for the fourth quarter and financial year ended March 31, 2025, backed by strong growth in its pharmaceutical services business.
Financial highlights: Total income for Q4FY25 stood at Rs 960.8 million, up 31.4% year-on-year.
EBITDA for the quarter was Rs 346.8 million, with margins steady at 36.1%.
Profit after tax (PAT) from continuing operations rose 31.2% YoY to Rs 183.2 million, maintaining a PAT margin of 19.1%.
Basic EPS for Q4FY25 was Rs 8.2, compared to Rs 6.3 a year ago.
For the full year FY25: Total income was reported at Rs 3,482 million, a 19.1% YoY increase.
EBITDA grew 29.1% to Rs 1,262 million with margins improving to 36.2%.
FY25 PAT rose sharply by 36.8% YoY to Rs 668 million, with a PAT margin of 19.2%.
Basic EPS for the year came in at Rs 30.
Strategic developments:
The Board of Directors has recommended a 1:1 bonus issue of equity shares and a final dividend of Rs 2 per share for FY25, subject to shareholder approval.
Vimta also announced a strategic expansion into Biologics Contract Research and Development (R&D) services. The new business will focus on novel biologic entities (NBEs), biosimilars, and peptide-based therapeutics, targeting full operationalization by Q3 FY26, with revenues expected to start from FY27.
Additionally, the company highlighted successful cGMP audit clearance by the European Medicines Agency (EMA) and a GCP audit by the Ministry of Health of Kazakhstan. Vimta's food division was awarded the 'Outstanding Laboratory Performance Award 2024' by CII for the second consecutive year.
The company completed the merger of EMTAC Laboratories, further strengthening its service portfolio.
Management comment:
Ms. Harita Vasireddi, Managing Director, stated, 'Our pharma services growth, capacity expansion, and deepened client engagements have contributed to our strong earnings performance. The new biologics initiative positions Vimta for the next phase of healthcare innovation.'
Disclaimer: This article is for informational purposes only. Investors are advised to consult certified financial advisors before making any investment decisions.
News desk at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
SPML Infra shares jump 4% on MIDC land allotment for Battery Storage manufacturing unit
By Aman Shukla Published on June 9, 2025, 10:10 IST SPML Infra shares surged 4% in morning trade following a significant development from the Maharashtra Industrial Development Corporation (MIDC). MIDC has allotted 99,000 square meters of land in the Supa Parner Industrial Park, Ahmednagar, Maharashtra, to SPML Infra. As of 10:10 AM, the shares were trading 2.81% higter at Rs 196.39. This land allotment is designated for setting up a Battery Energy Storage System (BESS) manufacturing unit, marking an important step in the company's expansion into the energy storage sector. The allotment is subject to payment of the premium and compliance with other terms outlined by MIDC. SPML Infra has already paid the earnest money and is actively working towards completing the premium payment as required. The move aligns with growing demand for energy storage solutions, especially battery-based systems that support renewable energy integration and grid stability. This new manufacturing facility is expected to strengthen SPML Infra's position in the clean energy infrastructure market. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
2 hours ago
- Business Upturn
NHPC shares jump nearly 3% after company announces commerical operation of 3rd phase of Karnisar Solar Power Project
NHPC Limited shares surged nearly 3% following the announcement of commercial operations commencement for the third phase of its Karnisar Solar Power Project in Bikaner, Rajasthan. As of 9:57 AM, the shares were trading 2.87% higher at Rs 91.87. The company successfully completed the trial run on June 5, 2025, and declared the Commercial Operation Date (COD) for the third phase, adding 53.57 MW of solar capacity effective June 7, 2025. With this development, the total operational capacity of the Karnisar Solar Power Project has reached 160.71 MW out of the planned 300 MW, marking a significant step in NHPC's renewable energy expansion. The phased commissioning of the project reflects NHPC's commitment to diversifying its energy portfolio beyond hydropower and supporting India's clean energy transition. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
2 hours ago
- Business Upturn
Murae Organisor secures agri commodity orders worth up to Rs 297 crore
By Aditya Bhagchandani Published on June 9, 2025, 10:25 IST Murae Organisor Limited (formerly Earum Pharmaceuticals Limited) has announced that it has secured supply orders worth up to Rs 297 crore from several domestic institutional clients in the FMCG, agri-processing, and commodity trade sectors. The company disclosed this major development in a filing with the BSE under Regulation 30 of the SEBI (LODR) Regulations. The supply orders encompass a wide range of essential agricultural commodities including mustard seeds, groundnuts, chickpeas, and other oilseeds and pulses. These will be delivered as per the schedules and locations specified by the clients. The first tranche of the order, amounting to around Rs 57 crore, is set to be executed within the next 30 days. The overall Rs 297 crore value will be fulfilled in phased tranches based on procurement timelines and client delivery milestones. According to the company, this move is part of a larger strategic shift toward scale-driven growth and improved operational leverage. Murae Organisor believes this development will substantially boost its revenue momentum over the coming quarters and strengthen its position as a reliable partner in the institutional agri-supply market. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
